State Street SPDR S&P Health Care Equipment ETF (XHE) Covered Calls

SPDR S&P Health Care Equipment ETF tracks an equal-weighted index of U.S. companies in the healthcare equipment and supplies industry. The fund provides broad exposure to firms involved in medical device manufacturing, surgical instruments, and healthcare technology. By utilizing an equal-weighting methodology, the fund ensures that mid-cap innovators have a significant impact on performance alongside industry giants, offering a diversified take on the domestic medical technology sector.

You can sell covered calls on State Street SPDR S&P Health Care Equipment ETF to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for XHE (prices last updated Mon 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

SPDR S&P Health Care Equipment ETF (XHE) is a targeted industry fund designed to capture the growth of the medical technology and supplies landscape. The fund tracks the S&P Health Care Equipment Select Industry Index, representing companies that design, manufacture, and distribute medical instruments, laboratory equipment, and patient monitoring systems. This sub-sector of healthcare is known for high research and development spending and frequent mergers and acquisitions.

The fund employs a modified equal-weight strategy, which differentiates it from broad healthcare benchmarks. In a market-cap-weighted index, a few massive conglomerates would dominate the portfolio. However, the equal-weight approach of this fund allows for greater exposure to mid-cap and small-cap firms that are often at the forefront of surgical robotics, cardiovascular technology, and orthopedic innovation. This structure provides a "pure play" on the MedTech industry without the concentration risk of large pharma or biotech.

Sector Dynamics and Operational Focus

The companies within the portfolio are driven by secular trends such as aging global populations, increased healthcare spending, and the "digitalization" of surgery. As of early 2026, the sector is increasingly focused on minimally invasive procedures and AI-integrated diagnostic tools. The fund’s holdings are exclusively U.S.-listed, reflecting the technological leadership and regulatory scale of the American healthcare manufacturing landscape. It serves as a vital tool for investors who want to target the "equipment" side of healthcare specifically.

Competitive Landscape

The fund competes with other healthcare sub-sector ETFs and the massive medical device firms that lead the industry globally. Key competitors and related optionable securities include:

1. iShares US Medical Devices ETF: The primary market-cap-weighted competitor, providing a more concentrated bet on the industry’s largest players.
2. Health Care Select Sector SPDR Fund: The broad-market healthcare benchmark; XHE is often used to "overweight" equipment relative to this core fund.
3. Abbott Laboratories: A global leader in medical devices and diagnostics, and a primary driver of sentiment for the entire XHE portfolio.
4. Intuitive Surgical: A major robotic-assisted surgery leader that represents the high-tech innovation segment tracked by the fund.
5. Stryker Corporation: A liquid and optionable industry leader in orthopedics and surgical equipment, serving as a core component of the index.

Strategic Outlook and Market Utility

The strategic utility of the fund is tied to the long-term demand for improved patient outcomes and hospital efficiency. While healthcare policy changes can create short-term volatility, the fundamental need for surgical equipment and life-saving medical devices ensures a robust market. The fund provides a way to express a view on the technological advancement of medical care, specifically targeting the high-margin business models inherent in medical device manufacturing.

Management focuses on maintaining high liquidity and ensuring that the fund remains an accurate representation of the evolving medical technology market. As companies in the portfolio pivot toward wearable health tech and remote patient monitoring, the fund’s rules-based index will continue to reflect the modernization of the healthcare sector. For active traders and institutional allocators, the fund remains a vital tool for capturing the cyclical growth and steady demand of the global medical technology industry.

Want more examples? XHB Covered Calls | XHR Covered Calls